About Index Trending news
Analyze
Pricing
Intarcia Therapeutics, Inc.

Intarcia Therapeutics, Inc.

Work at Intarcia Therapeutics, Inc.? Add yourself to this profile

Intarcia Therapeutics, Inc.

Intarcia Therapeutics is a biopharmaceutical company developing therapies fordiseases that require long-term chronic treatment.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Venture capital
$206,000,000
Private equity
$215,000,000
Employees

Team size

50+
Locations
HQ
$206,000,000 Venture capital
MassDevice , FinSMEs , bizjournals

Gates Foundation puts $140m into $206m round for Intarcia

$215,000,000 Private equity
Fortune

Diabetes ‘Unicorn’ Raises Final VC Round Before IPO

FinSMEs

Intarcia Therapeutics Closes $215M First Close of Equity Financing

Funding Health
$75,000,000 Debt financing
MassDevice

Intarcia raises another $75m, touts top-line safety data in pivotal trial